Codeine phosphate 2 MG/ML / phenylephrine hydrochloride 1 MG/ML / promethazine hydrochlori... — RxCUI 996757
RxNorm drug concept · Semantic clinical drug
RxCUI 996757
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI996757
Official nameCodeine phosphate 2 MG/ML / phenylephrine hydrochloride 1 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascodeine phosphate 10 MG / phenylephrine hydrochloride 5 MG / promethazine hydrochloride 6.25 MG per 5 ML Oral Solution; codeine phosphate 10 MG / phenylephrine HCl 5 MG / promethazine HCl 6.25 MG in 5 mL Oral Solution
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes, it's the same active ingredient, but used in very different ways depending on the form. The nasal spray delivers a tiny amount directly to the nasal lining to temporarily shri...
- I see phenylephrine in nasal sprays at the pharmacy AND as an IV drug in the hospital — is it really the same medication?
- You should check with your doctor first. Phenylephrine constricts blood vessels, which can raise blood pressure and put extra strain on the heart — even from a nasal spray. If you...
- Can I use the nasal spray if I have high blood pressure or heart disease?
🕸️ Concept Web — How Codeine phosphate 2 MG/ML / phenylephrine hydroc... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Codeine phosphate 2 MG/ML / phenylephrine hydrochloride 1 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution
RxCUI 996757 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 7
The active substance itself — no strength, form, or brand attached yet.
-
Codeine
2670IN -
Phenylephrine
8163IN -
Promethazine
8745IN -
Codeine / phenylephrine / promethazine
214449MIN -
Codeine phosphate
2672PIN -
Phenylephrine hydrochloride
8164PIN -
Promethazine hydrochloride
142445PIN
-
Codeine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Codeine / phenylephrine / promethazine Oral Solution
376076SCDF -
Codeine phosphate / phenylephrine hydrochloride / promethazine hydrochloride Oral Solution
2648406SCDFP -
Codeine / phenylephrine / promethazine Oral Liquid Product
1154830SCDG -
Codeine / phenylephrine / promethazine Oral Product
1154831SCDG -
Codeine phosphate / phenylephrine hydrochloride / promethazine hydrochloride Oral Liquid Product
2662855SCDGP -
Codeine phosphate / phenylephrine hydrochloride / promethazine hydrochloride Oral Product
2661553SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Codeine / phenylephrine / promethazine Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Codeine phosphate 2 MG/ML
832866SCDC -
Phenylephrine hydrochloride 1 MG/ML
996578SCDC -
Promethazine hydrochloride 1.25 MG/ML
991457SCDC
-
Codeine phosphate 2 MG/ML
Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Codeine phosphate 2 MG/ML
SCDC · 832866 -
Phenylephrine hydrochloride 1 MG/ML
SCDC · 996578 -
Promethazine hydrochloride 1.25 MG/ML
SCDC · 991457 -
Codeine / phenylephrine / promethazine Oral Solution
SCDF · 376076 -
Codeine phosphate / phenylephrine hydrochloride / promethazine hydrochloride Oral Solution
SCDFP · 2648406 -
Codeine / phenylephrine / promethazine Oral Liquid Product
SCDG · 1154830 -
Codeine / phenylephrine / promethazine Oral Product
SCDG · 1154831 -
Codeine phosphate / phenylephrine hydrochloride / promethazine hydrochloride Oral Liquid Product
SCDGP · 2662855 -
Codeine phosphate / phenylephrine hydrochloride / promethazine hydrochloride Oral Product
SCDGP · 2661553
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 996757 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 65162-0694-86 | 118 mL in 1 BOTTLE (65162-694-86) | Promethazine and Phenylephrine HCl, and Codeine Phosphate | Amneal Pharmaceuticals LLC | 2013-11-01 |
| 65162-0694-90 | 473 mL in 1 BOTTLE (65162-694-90) | Promethazine and Phenylephrine HCl, and Codeine Phosphate | Amneal Pharmaceuticals LLC | 2013-11-01 |
Observed labelers:
Amneal Pharmaceuticals LLC (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.